Abstract:Introduction A hybrid convergent approach (endocardial and epicardial ablation) demonstrated superior effectiveness in a recent randomized study for long‐standing persistent atrial fibrillation (LSPAF). Yet, there is a lack of real‐world, long‐term evidence as to which patients are best candidates for a hybrid convergent approach compared to standard endocardial cryoballoon pulmonary vein isolation (CB PVI). Methods and Results This single‐center, retrospective analysis spanning from 2010 to 2015 compared two distinctly different atrial fibrillation (AF) cohorts; one treated with stand‐alone cryoablation and one treated with a hybrid convergent approach. Baseline characteristics described candidates for each approach. The following criteria were utilized to determine CB PVI candidacy: (1) paroxysmal AF (PAF) (stage 3A) with failed class I/III antiarrhythmic drug (AAD) or (2) persistent/LSPAF (stage 3B/3C/3D) with failed class I/III AAD unwilling to undergo hybrid procedure. Selection criteria for the hybrid procedure included: (1) PAF refractory to both class I/III AAD and prior CB PVI (stage 3D) or (2) persistent/LSPAF (stage 3B/3C/3D) with failed class I/III AAD agreeable to hybrid procedure. Prior sternotomy was excluded. Serial electrocardiograms and continuous monitoring evaluated primary efficacy outcome of time‐to‐first recurrence of atrial arrhythmia after a 90‐day blanking period. Secondary outcomes were procedure‐related complications and AAD use (at discharge, 12, and 36 months). Kaplan‐Meier methods evaluated arrhythmia recurrence. Of 276 patients, 197 (64.2 ± 10.6 years old; 66.5% male; 74.1% 3A‐PAF; 18.3% 3B/3D‐persistent AF; 1.0% 3C‐LSPAF; 6.6% undetermined) underwent CB PVI and 79 (61.4 ± 8.1 years old; 83.5% male; 41.8% 3D‐PAF; 45.5% 3B/3D‐persistent AF; 12.7% 3C/3D‐LSPAF) underwent hybrid procedure. Arrhythmia freedom through 36 months was 55.2% for CB PVI and 50.4% for hybrid (p = .32). Class I AAD utilization at discharge occurred in 38 (19.3%) patients in the CB PVI group and 5 (6.3%) patients in the hybrid group (p = .01). CB PVI class I AAD utilization at 12 months occurred in 14 (9.0) patients versus 0 patients for hybrid convergent (p = .004). Patients with one or more adverse event were as follows: two (1.0%) in the CB PVI group (both transient phrenic nerve palsy) and three (3.7%) in the hybrid group (two with significant bleeding and one with wound infection) (p = .14). Conclusion This study demonstrated that patients with more complex forms of AF (3D‐PAF or 3B/3C/3D‐persistent/LSPAF) could be well managed with a convergent approach. In a real‐world evaluation, outcomes match safety and efficacy thresholds achieved for patients with earlier, less complex AF etiologies treated by CB PVI alone.

Does Surgical Ablation Energy Source Affect Long-Term Success of the Concomitant Cox Maze Procedure?

The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis

Concomitant ablation for non-paroxysmal atrial fibrillation: combined energy versus cryoablation alone

Randomized Trial of Concomitant Maze Procedure Using Nitrous Oxide- Versus Argon-Based Cryoablation

Surgical treatment of atrial fibrillation with bipolar radiofrequency ablation: mid-term results in one hundred consecutive patients

Efficacy of Catheter Ablation and Surgical CryoMaze Procedure in Patients with Long-Lasting Persistent Atrial Fibrillation and Rheumatic Heart Disease: a Randomized Trial

Comparison of Radiofrequency Ablation and Cryoablation for the Recovery of Atrial Contractility and Survival

Surgical treatment of chronic atrial fibrillation combined with rheumatic mitral valve disease: Effects of the cryo-maze procedure and predictors for late recurrence

Cryoballoon Vs. Robotic Magnetic Navigation-Guided Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation: 5-Year Outcomes

Comparison of the Mid-Term Outcomes of Robotic Magnetic Navigation-Guided Radiofrequency Ablation versus Cryoballoon Ablation for Persistent Atrial Fibrillation.

Right Minithoracotomy Versus Conventional Median Sternotomy for Patients Undergoing Mitral Valve Surgery and Cox-maze IV Ablation with Entirely Bipolar Radiofrequency Clamp

Concomitant Surgical Ablation in Paroxysmal vs Persistent Atrial Fibrillation During Mitral Surgery

A propensity matched comparison of robotic vs. traditional minimal access approach for mitral valve repair with concomitant cryoablation

Catheter Ablation or Surgical Therapy in Severe Atrial Functional Mitral Regurgitation Caused by Long‐Standing Persistent Atrial Fibrillation—Propensity Score Analysis

Safety and efficacy of Cox‐Maze procedure for atrial fibrillation during mitral valve surgery: a meta-analysis of randomized controlled trials

Effectiveness of Maze IV procedure versus thoracoscopic ablation for atrial fibrillation: a propensity score-matched analysis

A Comparison of Remote Magnetic Irrigated Tip Ablation versus Manual Catheter Irrigated Tip Catheter Ablation With and Without Force Sensing Feedback

P355Complete non-inducibility after radiofrequency ablation for electrical storm improves survival rates

Real‐world evidence demonstrates an appropriate atrial fibrillation population for hybrid convergent approach versus stand‐alone cryoballoon ablation: A long‐term safety and efficacy study

Comparison of Catheter Ablation and Surgical Ablation in Patients with Long-Standing Persistent Atrial Fibrillation and Rheumatic Heart Disease: A Four-Year Follow-Up Study

Acute and Long Term Outcomes of Catheter Ablation Using Remote Magnetic Navigation for the Treatment of Electrical Storm in Patients with Severe Ischemic Heart Failure.